These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16344016)

  • 1. A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women.
    Enjuanes A; Garcia-Giralt N; Supervía A; Nogués X; Ruiz-Gaspà S; Bustamante M; Mellibovsky L; Grinberg D; Balcells S; Díez-Pérez A
    Bone; 2006 May; 38(5):738-43. PubMed ID: 16344016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
    Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
    Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density.
    Riancho JA; Zarrabeitia MT; Valero C; Sañudo C; Mijares V; González-Macías J
    Eur J Endocrinol; 2006 Jul; 155(1):53-9. PubMed ID: 16793950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women.
    Somner J; McLellan S; Cheung J; Mak YT; Frost ML; Knapp KM; Wierzbicki AS; Wheeler M; Fogelman I; Ralston SH; Hampson GN
    J Clin Endocrinol Metab; 2004 Jan; 89(1):344-51. PubMed ID: 14715870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP19A1 rs10046 Pharmacogenetics in Postmenopausal Breast Cancer Patients Treated with Aromatase Inhibitors: One-year Follow-up.
    Baatjes K; Peeters A; McCaul M; Conradie MM; Apffelstaedt J; Conradie M; Kotze MJ
    Curr Pharm Des; 2020; 26(46):6007-6012. PubMed ID: 32900345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant association between common polymorphisms in the aromatase gene CYP19A1 and bone mineral density in postmenopausal women.
    Mullin BH; Carter KW; Lewis JR; Ingley E; Wilson SG; Prince RL
    Calcif Tissue Int; 2011 Dec; 89(6):464-71. PubMed ID: 21952832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
    García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
    Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Asn19Lys substitution in the osteoclast inhibitory lectin (OCIL) gene is associated with a reduction of bone mineral density in postmenopausal women.
    Pineda B; Laporta P; Cano A; García-Pérez MA
    Calcif Tissue Int; 2008 May; 82(5):348-53. PubMed ID: 18465072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
    Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
    J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density.
    Riancho JA; Zarrabeitia MT; Valero C; Sañudo C; Hernández JL; Amado JA; Zarrabeitia A; González-Macías J
    Bone; 2005 May; 36(5):917-25. PubMed ID: 15794932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
    Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. -1227C>T polymorphism in the pleiotrophin gene promoter influences bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Komadina R; Vindišar F; Marc J
    Mol Genet Metab; 2011 May; 103(1):76-80. PubMed ID: 21353611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the aromatase gene alleles with BMD: epidemiological and functional evidence.
    Riancho JA; Sañudo C; Valero C; Pipaón C; Olmos JM; Mijares V; Fernández-Luna JL; Zarrabeitia MT
    J Bone Miner Res; 2009 Oct; 24(10):1709-18. PubMed ID: 19419293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women: a genetic association analysis.
    Mlakar SJ; Osredkar J; Prezelj J; Marc J
    Menopause; 2012 Mar; 19(3):368-76. PubMed ID: 22089180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.
    Woo JH; Kim H; Kim JH; Kim JG
    Menopause; 2015 May; 22(5):512-9. PubMed ID: 25268406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.
    Napoli N; Rastelli A; Ma C; Yarramaneni J; Vattikutti S; Moskowitz G; Giri T; Mueller C; Kulkarny V; Qualls C; Ellis M; Armamento-Villareal R
    Bone; 2013 Aug; 55(2):309-14. PubMed ID: 23643682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
    Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
    Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the CLCN7 gene are associated with BMD in women.
    Pettersson U; Albagha OM; Mirolo M; Taranta A; Frattini A; McGuigan FE; Vezzoni P; Teti A; van Hul W; Reid DM; Villa A; Ralston SH
    J Bone Miner Res; 2005 Nov; 20(11):1960-7. PubMed ID: 16234969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
    Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.
    Sun T; Chen M; Lin X; Yu R; Zhao Y; Wang J
    Int Immunopharmacol; 2014 Sep; 22(1):200-3. PubMed ID: 24975835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.